Orbimed Advisors - CATALYST BIOSCIENCES INC ownership

CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 93 filers reported holding CATALYST BIOSCIENCES INC in Q1 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of CATALYST BIOSCIENCES INC
ValueSharesWeighting
Q4 2021$1,581,000
-85.8%
1,729,402
-36.2%
0.02%
-83.6%
Q3 2021$11,145,000
+21.5%
2,711,600
+28.0%
0.12%
+31.2%
Q2 2021$9,174,000
-14.1%
2,118,6000.0%0.09%
-7.0%
Q1 2021$10,678,0002,118,6000.10%
Other shareholders
CATALYST BIOSCIENCES INC shareholders Q1 2021
NameSharesValueWeighting ↓
Sio Capital Management, LLC 471,448$5,502,0003.04%
ACUTA CAPITAL PARTNERS, LLC 830,000$9,686,0001.72%
NEXTHERA CAPITAL LP 786,865$9,183,0001.42%
Ghost Tree Capital, LLC 355,000$4,143,0001.22%
Point72 Europe (London) LLP 83,500$974,0000.52%
Virtus ETF Advisers LLC 31,061$362,0000.32%
Eventide Asset Management 246,000$2,871,0000.12%
Kalos Management, Inc. 8,500$244,0000.11%
MARSHALL WACE, LLP 550,352$6,423,0000.10%
GSA CAPITAL PARTNERS LLP 157,145$1,834,0000.09%
View complete list of CATALYST BIOSCIENCES INC shareholders